Regarding Project Duration for Contract MRs

Introduction

When working as a contract MR, "project duration" is an issue that one must always be conscious of. Unlike direct employees of a pharmaceutical company, for contract MRs who work under a contract with the manufacturer, the duration of a project and the timing of its renewal or termination are major concerns that directly affect their livelihood and future planning. In this article, I will explain the reality of project durations in detail, incorporating my own experiences.

Basic Contract Duration Mechanism

In many projects, a period of two or three years is set as the base duration, after which renewal is common if both parties agree.

In projects for domestic manufacturers, it is not rare for people to be involved in the same project for more than five years, repeating renewals every year. I have actually seen cases where people have been on the same project for over 10 years.

When someone has been on the same project for over 10 years, you might think, "If they have been there that long, wouldn't it be better to become a direct employee?" However, I have heard that there are cases where becoming a direct employee is difficult due to factors such as age.

Characteristics of Foreign-Affiliated Projects

On the other hand, projects for foreign-affiliated manufacturers have slightly different characteristics from domestic ones. My impression is that there are not many cases where contracts are renewed for more than three years in foreign-affiliated companies.

The background to this lies in the purpose for which foreign-affiliated manufacturers utilize CSOs. In foreign-affiliated companies, there is a common style of utilizing CSO MRs only for the limited period surrounding a new drug launch, and there are many projects where the concept of "renewal" does not really exist. Once the launch phase is over, the project itself comes to an end.

One of the projects I was assigned to was exactly that case. The foreign-affiliated manufacturer was utilizing a large number of contract MRs at the time of a new drug launch, and not only the CSO I belonged to, but multiple other CSO companies were being used simultaneously. It was a situation where there were multiple MRs from other CSOs among my peers in the assigned project.

At one of those CSOs, an MR told me, "We are dispatched on the premise that we will transfer to the manufacturer once the contract period ends." I was surprised that such a contract existed, but almost everyone who was actually at that company did transfer. It seems there are various arrangements between CSOs and manufacturers, and since much of the contract content is a black box, the reality is that details are rarely conveyed to individual MRs.

Mass Contract Termination Earlier Than Planned

What you must be careful about is the case where a project is suddenly terminated without waiting for the originally scheduled period. I have actually experienced this myself.

In one project, the manufacturer shifted to a policy of "not using contract MRs for the time being," and all CSO employees who had been dispatched were to have their contracts terminated at once. At that time, interviews were conducted with everyone to see if they wished to transfer to the manufacturer.

I did not wish to transfer because I did not feel any personal benefits regarding that manufacturer's corporate culture, work location, or compensation. On the other hand, I heard that several people who did wish to transfer were able to do so successfully. This means that the end of a project can sometimes lead to a path toward employment with the manufacturer.

Also, I have actually seen cases where even if the individual wanted to renew, the client on-site (the office manager) refused the renewal, and the person was reassigned to another project. I heard from the client manager who refused the renewal later that they had taken issue with basic behaviors, such as not meeting deadlines for daily submissions, which is why they refused the renewal.
Regardless of your own intentions or achievements, there are times when the continuation of a contract is not granted—this is also one of the realities of being a contract MR.

Early Retirement Programs and the Impact on Contract MRs

In recent years, pharmaceutical manufacturers have been successively calling for early retirement. In such situations, contract MRs are often the first to have their contracts terminated before direct employees.

I have also experienced this situation. Initially, rumors spread that "all contract MRs will have their contracts terminated," but it seemed the manufacturer could not read how many employees would apply for early retirement, and in the end, interviews were conducted with contract MRs as well to see if they wished to remain.

Since I was still young, I wanted to experience other projects and work locations, so I requested reassignment to another project. On the other hand, another member of the same project had been assigned to fill in for an MR on maternity leave, so they received a direct request from the manufacturer to "stay," and they continued. That person received an offer from the manufacturer about a year later and successfully transferred.
As you can see, it cannot be said unconditionally that calling for early retirement equals contract termination; flexible responses are taken depending on the situation.
I cannot deny that it feels like being pushed around, but one must anticipate such fluid situations to a certain extent.

Conclusion

The project duration for contract MRs is greatly influenced by the differences between domestic and foreign companies, as well as the circumstances of the manufacturer. While there are cases where one can play an active role in the same project for a long time, there are also times when termination is announced in an unexpected way. In addition, the contract details between CSOs and manufacturers are often a black box, and arrangements including the possibility of transfer may be moving behind the scenes.

A career as a contract MR involves working while facing these uncertainties. That is precisely why I feel it is important to never neglect gathering information and to always be conscious of the next step.